{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32855766", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "14"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "08", "Day": "12"}], "Language": ["eng"], "ELocationID": ["7534693", "10.1155/2020/7534693"], "Journal": {"ISSN": "1942-0994", "JournalIssue": {"Volume": "2020", "PubDate": {"Year": "2020"}}, "Title": "Oxidative medicine and cellular longevity", "ISOAbbreviation": "Oxid Med Cell Longev"}, "ArticleTitle": "Beta-Blockers and Berberine: A Possible Dual Approach to Contrast Neuroblastoma Growth and Progression.", "Pagination": {"StartPage": "7534693", "MedlinePgn": "7534693"}, "Abstract": {"AbstractText": ["The use of nutraceuticals during cancer treatment is a long-lasting debate. Berberine (BBR) is an isoquinoline quaternary alkaloid extracted from a variety of medicinal plants. BBR has been shown to have therapeutic effects in different pathologies, particularly in cancer, where it affects pathways involved in tumor progression. In neuroblastoma, the most common extracranial childhood solid tumor, BBR, reduces tumor growth by regulating both stemness and differentiation features and by inducing apoptosis. At the same time, the inhibition of <i>\u03b2</i>-adrenergic signaling leads to a reduction in growth and increase of differentiation of neuroblastoma. In this review, we summarize the possible beneficial effects of BBR in counteracting tumor growth and progression in various types of cancer and, in particular, in neuroblastoma. However, BBR administration, besides its numerous beneficial effects, presents a few side effects due to inhibition of MAO A enzyme in neuroblastoma cells. Therefore, herein, we proposed a novel therapeutic strategy to overcome side effects of BBR administration consisting of concomitant administration of BBR together with <i>\u03b2</i>-blockers in neuroblastoma."], "CopyrightInformation": "Copyright \u00a9 2020 Maura Calvani et al."}, "AuthorList": [{"Identifier": ["0000-0003-0750-4706"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Paediatric Haematology-Oncology, A. Meyer University Children's Hospital, Florence, Italy."}], "LastName": "Calvani", "ForeName": "Maura", "Initials": "M"}, {"Identifier": ["0000-0001-7184-0734"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Paediatric Haematology-Oncology, A. Meyer University Children's Hospital, Florence, Italy."}, {"Identifier": [], "Affiliation": "Department of Health Sciences, University of Florence, Florence, Italy."}], "LastName": "Subbiani", "ForeName": "Angela", "Initials": "A"}, {"Identifier": ["0000-0001-6252-3825"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Paediatric Haematology-Oncology, A. Meyer University Children's Hospital, Florence, Italy."}, {"Identifier": [], "Affiliation": "Department of Health Sciences, University of Florence, Florence, Italy."}], "LastName": "Bruno", "ForeName": "Gennaro", "Initials": "G"}, {"Identifier": ["0000-0003-1770-2423"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Paediatric Haematology-Oncology, A. Meyer University Children's Hospital, Florence, Italy."}], "LastName": "Favre", "ForeName": "Claudio", "Initials": "C"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oxid Med Cell Longev", "NlmUniqueID": "101479826", "ISSNLinking": "1942-0994"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Adrenergic beta-Antagonists"}, {"RegistryNumber": "0I8Y3P32UF", "NameOfSubstance": "Berberine"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Adrenergic beta-Antagonists"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Berberine"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Brain Neoplasms"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Disease Progression"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Neuroblastoma"}], "CoiStatement": "The authors have no relevant disclosures of potential conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Brodeur G. M. Neuroblastoma: biological insights into a clinical enigma. Nature Reviews Cancer. 2003;3(3):203\u2013216. doi: 10.1038/nrc1014.", "ArticleIdList": ["10.1038/nrc1014", "12612655"]}, {"Citation": "Mueller S., Matthay K. K. Neuroblastoma: biology and staging. Current Oncology Reports. 2009;11(6):431\u2013438. doi: 10.1007/s11912-009-0059-6.", "ArticleIdList": ["10.1007/s11912-009-0059-6", "19840520"]}, {"Citation": "Trigg R. M., Turner S. D. ALK in Neuroblastoma: Biological and Therapeutic Implications. Cancers. 2018;41(6):p. 113.", "ArticleIdList": ["PMC5923368", "29642598"]}, {"Citation": "Campbell K., Gastier-Foster J. M., Mann M., et al. Association ofMYCNcopy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group. Cancer. 2017;123(21):4224\u20134235. doi: 10.1002/cncr.30873.", "ArticleIdList": ["10.1002/cncr.30873", "PMC5650521", "28696504"]}, {"Citation": "Look A. T., Hayes F. A., Shuster J. J., et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a pediatric oncology group study. Journal of Clinical Oncology. 1991;9(4):581\u2013591. doi: 10.1200/JCO.1991.9.4.581.", "ArticleIdList": ["10.1200/JCO.1991.9.4.581", "2066755"]}, {"Citation": "Weiss W. A., Aldape K., Mohapatra G., Feuerstein B. G., Bishop J. M. Targeted expression of MYCN causes neuroblastoma in transgenic mice. The EMBO Journal. 1997;16(11):2985\u20132995. doi: 10.1093/emboj/16.11.2985.", "ArticleIdList": ["10.1093/emboj/16.11.2985", "PMC1169917", "9214616"]}, {"Citation": "Yaari S., Jacob-Hirsch J., Amariglio N., Haklai R., Rechavi G., Kloog Y. Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest. Clinical Cancer Research. 2005;11(12):4321\u20134330. doi: 10.1158/1078-0432.CCR-04-2071.", "ArticleIdList": ["10.1158/1078-0432.CCR-04-2071", "15958613"]}, {"Citation": "Tonelli R., Purgato S., Camerin C., et al. Anti-gene peptide nucleic acid specifically inhibits MYCN expression in human neuroblastoma cells leading to cell growth inhibition and apoptosis. Molecular Cancer Therapeutics. 2005;4(5):779\u2013786. doi: 10.1158/1535-7163.MCT-04-0213.", "ArticleIdList": ["10.1158/1535-7163.MCT-04-0213", "15897242"]}, {"Citation": "Chipumuro E., Marco E., Christensen C. L., et al. CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer. Cell. 2014;159(5):1126\u20131139. doi: 10.1016/j.cell.2014.10.024.", "ArticleIdList": ["10.1016/j.cell.2014.10.024", "PMC4243043", "25416950"]}, {"Citation": "Garaventa A., Parodi S., de Bernardi B., et al. Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry. European Journal of Cancer. 2009;45(16):2835\u20132842. doi: 10.1016/j.ejca.2009.06.010.", "ArticleIdList": ["10.1016/j.ejca.2009.06.010", "19616426"]}, {"Citation": "Kushner B. H., Modak S., Kramer K., et al. Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era. Cancer. 2014;120(13):2050\u20132059. doi: 10.1002/cncr.28687.", "ArticleIdList": ["10.1002/cncr.28687", "PMC4326052", "24691684"]}, {"Citation": "Schleiermacher G., Javanmardi N., Bernard V., et al. Emergence of new ALK mutations at relapse of neuroblastoma. Journal of Clinical Oncology. 2014;32(25):2727\u20132734. doi: 10.1200/JCO.2013.54.0674.", "ArticleIdList": ["10.1200/JCO.2013.54.0674", "25071110"]}, {"Citation": "Padovan-Merhar O. M., Raman P., Ostrovnaya I., et al. Enrichment of targetable mutations in the relapsed neuroblastoma genome. PLoS Genetics. 2016;12(12):p. e1006501. doi: 10.1371/journal.pgen.1006501.", "ArticleIdList": ["10.1371/journal.pgen.1006501", "PMC5172533", "27997549"]}, {"Citation": "Zhu S., Lee J. S., Guo F., et al. Activated ALK collaborates with MYCN in neuroblastoma pathogenesis. Cancer Cell. 2012;21(3):362\u2013373. doi: 10.1016/j.ccr.2012.02.010.", "ArticleIdList": ["10.1016/j.ccr.2012.02.010", "PMC3315700", "22439933"]}, {"Citation": "Berry T., Luther W., Bhatnagar N., et al. The _ALKF1174L_ Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma. Cancer Cell. 2012;22(1):117\u2013130. doi: 10.1016/j.ccr.2012.06.001.", "ArticleIdList": ["10.1016/j.ccr.2012.06.001", "PMC3417812", "22789543"]}, {"Citation": "Sch\u00f6nherr C., Ruuth K., Kamaraj S., et al. Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of _MYCN_ in neuroblastoma cells. Oncogene. 2012;31(50):5193\u20135200. doi: 10.1038/onc.2012.12.", "ArticleIdList": ["10.1038/onc.2012.12", "22286764"]}, {"Citation": "De Brouwer S., De Preter K., Kumps C., et al. Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification. Clinical Cancer Research. 2010;16(17):4353\u20134362. doi: 10.1158/1078-0432.CCR-09-2660.", "ArticleIdList": ["10.1158/1078-0432.CCR-09-2660", "20719933"]}, {"Citation": "Monclair T., Brodeur G. M., Ambros P. F., et al. The international neuroblastoma risk group (INRG) staging system: an INRG task force report. Journal of Clinical Oncology. 2009;27(2):298\u2013303. doi: 10.1200/JCO.2008.16.6876.", "ArticleIdList": ["10.1200/JCO.2008.16.6876", "PMC2650389", "19047290"]}, {"Citation": "Lands A. M., Arnold A., Mcauliff J. P., Luduena F. P., Brown T. G. Differentiation of receptor systems activated by sympathomimetic amines. Nature. 1967;214(5088):597\u2013598. doi: 10.1038/214597a0.", "ArticleIdList": ["10.1038/214597a0", "6036174"]}, {"Citation": "Emorine L., Marullo S., Briend-Sutren M., et al. Molecular characterization of the human beta 3-adrenergic receptor. Science. 1989;245(4922):1118\u20131121. doi: 10.1126/science.2570461.", "ArticleIdList": ["10.1126/science.2570461", "2570461"]}, {"Citation": "Michel M. C., Gravas S. Safety and tolerability of \u03b23-adrenoceptor agonists in the treatment of overactive bladder syndrome - insight from transcriptosome and experimental studies. Expert Opinion on Drug Safety. 2016;15(5):647\u2013657. doi: 10.1517/14740338.2016.1160055.", "ArticleIdList": ["10.1517/14740338.2016.1160055", "26954275"]}, {"Citation": "Cernecka H., Sand C., Michel M. C. The odd sibling: features of\u03b23-Adrenoceptor pharmacology. Molecular Pharmacology. 2014;86(5):479\u2013484. doi: 10.1124/mol.114.092817.", "ArticleIdList": ["10.1124/mol.114.092817", "24890609"]}, {"Citation": "Michel M. C., Bond R. A., Summers R. J. Adrenoceptors\u2014new roles for old players. British Journal of Pharmacology. 2019;176(14):2339\u20132342. doi: 10.1111/bph.14701.", "ArticleIdList": ["10.1111/bph.14701", "PMC6592857", "31240712"]}, {"Citation": "Schuller H. M., Cole B. Regulation of cell proliferation by \u03b2-adrenergjc receptors in a human lung adenocarcinoma cell line. Carcinogenesis. 1989;10(9):1753\u20131755. doi: 10.1093/carcin/10.9.1753.", "ArticleIdList": ["10.1093/carcin/10.9.1753", "2569945"]}, {"Citation": "Antoni M. H., Lutgendorf S. K., Cole S. W., et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nature Reviews. Cancer. 2006;6(3):240\u2013248. doi: 10.1038/nrc1820.", "ArticleIdList": ["10.1038/nrc1820", "PMC3146042", "16498446"]}, {"Citation": "Cole S. W., Sood A. K. Molecular pathways: beta-adrenergic signaling in cancer: figure 1. Clinical Cancer Research. 2012;18(5):1201\u20131206. doi: 10.1158/1078-0432.CCR-11-0641.", "ArticleIdList": ["10.1158/1078-0432.CCR-11-0641", "PMC3294063", "22186256"]}, {"Citation": "L\u00e9aut\u00e9-Labr\u00e8ze C., de la Roque E. D., Hubiche T., Boralevi F., Thambo J. B., Ta\u00efeb A. Propranolol for severe hemangiomas of infancy. The New England Journal of Medicine. 2009;358(24):2649\u20132651.", "ArticleIdList": ["18550886"]}, {"Citation": "Stiles J., Amaya C., Pham R., et al. Propranolol treatment of infantile hemangioma endothelial cells: a molecular analysis. Experimental and Therapeutic Medicine. 2012;4(4):594\u2013604. doi: 10.3892/etm.2012.654.", "ArticleIdList": ["10.3892/etm.2012.654", "PMC3501380", "23170111"]}, {"Citation": "Montoya A., Amaya C. N., Belmont A., et al. Use of non-selective \u03b2-blockers is associated with decreased tumor proliferative indices in early stage breast cancer. Oncotarget. 2017;8(4):6446\u20136460. doi: 10.18632/oncotarget.14119.", "ArticleIdList": ["10.18632/oncotarget.14119", "PMC5351644", "28031536"]}, {"Citation": "Sood A. K., Bhatty R., Kamat A. A., et al. Stress hormone-mediated invasion of ovarian cancer cells. Clinical Cancer Research. 2006;12(2):369\u2013375. doi: 10.1158/1078-0432.CCR-05-1698.", "ArticleIdList": ["10.1158/1078-0432.CCR-05-1698", "PMC3141061", "16428474"]}, {"Citation": "Watkins J. L., Thaker P. H., Nick A. M., et al. Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer. Cancer. 2015;121(19):3444\u20133451. doi: 10.1002/cncr.29392.", "ArticleIdList": ["10.1002/cncr.29392", "PMC4575637", "26301456"]}, {"Citation": "Moretti S., Massi D., Farini V., et al. _\u03b2_ -adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines. Laboratory Investigation. 2013;93(3):279\u2013290. doi: 10.1038/labinvest.2012.175.", "ArticleIdList": ["10.1038/labinvest.2012.175", "23318885"]}, {"Citation": "Calvani M., Pelon F., Comito G., et al. Norepinephrine promotes tumor microenvironment reactivity through \u03b23-adrenoreceptors during melanoma progression. Oncotarget. 2015;6(7):4615\u20134632. doi: 10.18632/oncotarget.2652.", "ArticleIdList": ["10.18632/oncotarget.2652", "PMC4467103", "25474135"]}, {"Citation": "Perrone M. G., Notarnicola M., Caruso M. G., Tutino V., Scilimati A. Upregulation of \u03b23-Adrenergic receptor mRNA in human colon cancer: a preliminary study. Oncology. 2008;75(3-4):224\u2013229. doi: 10.1159/000163851.", "ArticleIdList": ["10.1159/000163851", "18852493"]}, {"Citation": "Goldfarb Y., Sorski L., Benish M., Levi B., Melamed R., Ben-Eliyahu S. Improving postoperative immune status and resistance to cancer Metastasiss. Annals of Surgery. 2011;253(4):798\u2013810. doi: 10.1097/SLA.0b013e318211d7b5.", "ArticleIdList": ["10.1097/SLA.0b013e318211d7b5", "21475023"]}, {"Citation": "Sloan E. K., Priceman S. J., Cox B. F., et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Research. 2010;70(18):7042\u20137052. doi: 10.1158/0008-5472.CAN-10-0522.", "ArticleIdList": ["10.1158/0008-5472.CAN-10-0522", "PMC2940980", "20823155"]}, {"Citation": "Palm D., Lang K., Niggemann B., et al. The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by \u03b2-blockers. International Journal of Cancer. 2006;118(11):2744\u20132749. doi: 10.1002/ijc.21723.", "ArticleIdList": ["10.1002/ijc.21723", "16381019"]}, {"Citation": "Inbar S., Neeman E., Avraham R., Benish M., Rosenne E., Ben-Eliyahu S. Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity. PLoS One. 2011;6(4):p. e19246. doi: 10.1371/journal.pone.0019246.", "ArticleIdList": ["10.1371/journal.pone.0019246", "PMC3084788", "21559428"]}, {"Citation": "Thaker P. H., Han L. Y., Kamat A. A., et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nature Medicine. 2006;12(8):939\u2013944. doi: 10.1038/nm1447.", "ArticleIdList": ["10.1038/nm1447", "16862152"]}, {"Citation": "Hassan S., Karpova Y., Flores A., D\u2019Agostino R., Kulik G. Surgical stress delays prostate involution in mice. PLoS One. 2013;8(11):p. e78175. doi: 10.1371/journal.pone.0078175.", "ArticleIdList": ["10.1371/journal.pone.0078175", "PMC3819334", "24223137"]}, {"Citation": "Zahalka A. H., Arnal-Estap\u00e9 A., Maryanovich M., et al. Adrenergic nerves activate an angio-metabolic switch in prostate cancer. Science. 2017;358(6361):321\u2013326. doi: 10.1126/science.aah5072.", "ArticleIdList": ["10.1126/science.aah5072", "PMC5783182", "29051371"]}, {"Citation": "P\u00e9rez-Say\u00e1ns M., Somoza-Mart\u00edn J. M., Barros-Angueira F., Diz P. G., G\u00e1ndara Rey J. M., Garc\u00eda-Garc\u00eda A. \u03b2-Adrenergic receptors in cancer: therapeutic implications. Oncology Resarch. 2010;19(1):45\u201354. doi: 10.3727/096504010X12828372551867.", "ArticleIdList": ["10.3727/096504010X12828372551867", "21141740"]}, {"Citation": "Huang X. E., Hamajima N., Saito T., et al. Possible association of beta2- and beta3-adrenergic receptor gene polymorphisms with susceptibility to breast cancer. Breast Cancer Research. 2001;3(4):264\u2013269. doi: 10.1186/bcr304.", "ArticleIdList": ["10.1186/bcr304", "PMC34110", "11434877"]}, {"Citation": "Babol K., Przybylowska K., Lukaszek M., Pertynski T., Blasiak J. An association between the Trp64Arg polymorphism in the beta3-adrenergic receptor gene and endometrial cancer and obesity. Journal of Experimental & Clinical Cancer Research. 2004;23(4):669\u2013674.", "ArticleIdList": ["15743038"]}, {"Citation": "Rai R., Kim J., Misra S., Kumar A., Mittal B. A multiple interaction analysis reveals ADRB3 as a potential candidate for gallbladder cancer predisposition via a complex interaction with other candidate gene variations. International Journal of Molecular Sciences. 2015;16(12):28038\u201328049. doi: 10.3390/ijms161226077.", "ArticleIdList": ["10.3390/ijms161226077", "PMC4691025", "26602921"]}, {"Citation": "Magnon C., Hall S. J., Lin J., et al. Autonomic nerve development contributes to prostate cancer progression. Science. 2013;341(6142):p. 1236361. doi: 10.1126/science.1236361.", "ArticleIdList": ["10.1126/science.1236361", "23846904"]}, {"Citation": "Dal Monte M., Casini G., Filippi L., Nicchia G. P., Svelto M., Bagnoli P. Functional involvement of \u03b23-adrenergic receptors in melanoma growth and vascularization. Journal of Molecular Medicine. 2013;91(12):1407\u20131419. doi: 10.1007/s00109-013-1073-6.", "ArticleIdList": ["10.1007/s00109-013-1073-6", "23907236"]}, {"Citation": "Calvani M., Bruno G., Dal Monte M., et al. \u03b23\u2010Adrenoceptor as a potential immuno-suppressor agent in melanoma. British Journal of Pharmacology. 2019;176(14):2509\u20132524. doi: 10.1111/bph.14660.", "ArticleIdList": ["10.1111/bph.14660", "PMC6592854", "30874296"]}, {"Citation": "Brodeur G. M., Pritchard J., Berthold F., et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. Journal of Clinical Oncology. 1993;11(8):1466\u20131477. doi: 10.1200/JCO.1993.11.8.1466.", "ArticleIdList": ["10.1200/JCO.1993.11.8.1466", "8336186"]}, {"Citation": "Pritchard J., Barnes J., Germond S., et al. Stage and urinary catecholamine metabolite excretion in neuroblastoma. Lancet. 1989;334(8661):514\u2013515. doi: 10.1016/s0140-6736(89)92135-1.", "ArticleIdList": ["10.1016/s0140-6736(89)92135-1", "2570230"]}, {"Citation": "Wolter J. K., Wolter N. E., Blanch A., et al. Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma. Oncotarget. 2014;5(1):161\u2013172. doi: 10.18632/oncotarget.1083.", "ArticleIdList": ["10.18632/oncotarget.1083", "PMC3960198", "24389287"]}, {"Citation": "Pasquier E., Street J., Pouchy C., et al. _\u03b2_ -blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma. British Journal of Cancer. 2013;108(12):2485\u20132494. doi: 10.1038/bjc.2013.205.", "ArticleIdList": ["10.1038/bjc.2013.205", "PMC3694229", "23695022"]}, {"Citation": "Bruno G., Cencetti F., Pini A., et al. \u03923-adrenoreceptor blockade reduces tumor growth and increases neuronal differentiation in neuroblastoma via SK2/S1P2 modulation. Oncogene. 2020;39(2):368\u2013384. doi: 10.1038/s41388-019-0993-1.", "ArticleIdList": ["10.1038/s41388-019-0993-1", "PMC6949192", "31477835"]}, {"Citation": "Laverdi\u00e8re C., Liu Q., Yasui Y., et al. Long-term outcomes in survivors of neuroblastoma: a report from the childhood cancer survivor study. JNCI Journal of the National Cancer Institute. 2009;101(16):1131\u20131140. doi: 10.1093/jnci/djp230.", "ArticleIdList": ["10.1093/jnci/djp230", "PMC2728747", "19648511"]}, {"Citation": "Su D., Cheng Y., Liu M., et al. Comparision of piceid and resveratrol in antioxidation and antiproliferation activities in vitro. PLoS ONE. 2013;8(1):p. e54505. doi: 10.1371/journal.pone.0054505.", "ArticleIdList": ["10.1371/journal.pone.0054505", "PMC3546968", "23342161"]}, {"Citation": "Wu J. M., Hsieh T. C., Wang Z. Cardioprotection by resveratrol: a review of effects/targets in cultured cells and animal tissues. American Journal of Cardiovascular Disease. 2011;1(1):38\u201347.", "ArticleIdList": ["PMC3253513", "22254184"]}, {"Citation": "Park S., Lim J., Kim J. R., Cho S. Inhibitory effects of resveratrol on hepatitis B virus X protein-induced hepatocellular carcinoma. Journal of Veterinary Science. 2017;18(4):419\u2013429. doi: 10.4142/jvs.2017.18.4.419.", "ArticleIdList": ["10.4142/jvs.2017.18.4.419", "PMC5746434", "28385009"]}, {"Citation": "Rimando A., Suh N. Biological/chemopreventive activity of stilbenes and their effect on colon cancer. Planta Medica. 2008;74(13):1635\u20131643. doi: 10.1055/s-0028-1088301.", "ArticleIdList": ["10.1055/s-0028-1088301", "18843589"]}, {"Citation": "Fuggetta M. P., D??Atri S., Lanzilli G., et al. In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide. Melanoma Research. 2004;14(3):189\u2013196. doi: 10.1097/01.cmr.0000130007.54508.b2.", "ArticleIdList": ["10.1097/01.cmr.0000130007.54508.b2", "15179187"]}, {"Citation": "van Ginkel P. R., Sareen D., Subramanian L., et al. Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clinical Cancer Research. 2007;13(17):5162\u20135169. doi: 10.1158/1078-0432.CCR-07-0347.", "ArticleIdList": ["10.1158/1078-0432.CCR-07-0347", "17785572"]}, {"Citation": "Rahman M. A., Kim N. H., Kim S. H., Oh S. M., Huh S. O. Antiproliferative and cytotoxic effects of resveratrol in mitochondria-mediated apoptosis in rat B103 neuroblastoma cells. The Korean Journal of Physiology & Pharmacology. 2012;16(5):321\u2013326. doi: 10.4196/kjpp.2012.16.5.321.", "ArticleIdList": ["10.4196/kjpp.2012.16.5.321", "PMC3484516", "23118555"]}, {"Citation": "Graham R. M., Hernandez F., Puerta N., de Angulo G., Webster K. A., Vanni S. Resveratrol augments ER stress and the cytotoxic effects of glycolytic inhibition in neuroblastoma by downregulating Akt in a mechanism independent of SIRT1. Experimental & Molecular Medicine. 2016;48(2):p. e210. doi: 10.1038/emm.2015.116.", "ArticleIdList": ["10.1038/emm.2015.116", "PMC4892869", "26891914"]}, {"Citation": "Soto B. L., Hank J. A., Van De Voort T. J., et al. The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model. Cancer Immunology, Immunotherapy. 2011;60(5):731\u2013738. doi: 10.1007/s00262-011-0971-0.", "ArticleIdList": ["10.1007/s00262-011-0971-0", "PMC3094716", "21340652"]}, {"Citation": "Kuptniratsaikul V., Dajpratham P., Taechaarpornkul W., et al. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clinical Intervention in Aging. 2014;9:451\u2013458. doi: 10.2147/cia.s58535.", "ArticleIdList": ["10.2147/cia.s58535", "PMC3964021", "24672232"]}, {"Citation": "Aggarwal B. B., Harikumar K. B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. The International Journal of Biochemistry & Cell Biology. 2009;41(1):40\u201359. doi: 10.1016/j.biocel.2008.06.010.", "ArticleIdList": ["10.1016/j.biocel.2008.06.010", "PMC2637808", "18662800"]}, {"Citation": "Sahebkar A., Serban M.-C., Ursoniu S., Banach M. Effect of curcuminoids on oxidative stress: A systematic review and meta- analysis of randomized controlled trials. Journal of Functional Foods. 2015;18(part B):898\u2013909. doi: 10.1016/j.jff.2015.01.005.", "ArticleIdList": ["10.1016/j.jff.2015.01.005"]}, {"Citation": "Panahi Y., Hosseini M. S., Khalili N., et al. Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: a post-hoc analysis of a randomized controlled trial. Biomedicine & Pharmacotherapy. 2016;82:578\u2013582. doi: 10.1016/j.biopha.2016.05.037.", "ArticleIdList": ["10.1016/j.biopha.2016.05.037", "27470399"]}, {"Citation": "Henrotin Y., Priem F., Mobasheri A. Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management. Springer Plus. 2013;2(1):p. 56. doi: 10.1186/2193-1801-2-56.", "ArticleIdList": ["10.1186/2193-1801-2-56", "PMC3591524", "23487030"]}, {"Citation": "Wright L., Frye J., Gorti B., Timmermann B., Funk J. Bioactivity of turmeric-derived curcuminoids and related metabolites in breast cancer. Current Pharmaceutical Design. 2013;19(34):6218\u20136225. doi: 10.2174/1381612811319340013.", "ArticleIdList": ["10.2174/1381612811319340013", "PMC3883055", "23448448"]}, {"Citation": "Sidhar H., Giri R. K. Induction of _Bex_ genes by curcumin is associated with apoptosis and activation of p53 in N2a neuroblastoma cells. Scientific Reports. 2017;7(1):p. 41420. doi: 10.1038/srep41420.", "ArticleIdList": ["10.1038/srep41420", "PMC5286441", "28145533"]}, {"Citation": "Chen X.-W., Di Y. M., Zhang J., Zhou Z.-W., Li C. G., Zhou S.-F. Interaction of herbal compounds with biological targets: a case study with berberine. The Scientific World Journal. 2012;2012:31. doi: 10.1100/2012/708292.708292", "ArticleIdList": ["10.1100/2012/708292", "PMC3504405", "23213296"]}, {"Citation": "Tillhon M., Guam\u00e1n Ortiz L. M., Lombardi P., Scovassi A. I. Berberine: new perspectives for old remedies. Biochemical Pharmacology. 2012;84(10):1260\u20131267. doi: 10.1016/j.bcp.2012.07.018.", "ArticleIdList": ["10.1016/j.bcp.2012.07.018", "22842630"]}, {"Citation": "Duan Y., Liu T., Zhou Y., Dou T., Yang Q. \u200aGlycoside hydrolase family 18 and 20 enzymes are novel targets of the traditional medicine berberine. Journal of Biological Chemistry. 2018;293(40):15429\u201315438. doi: 10.1074/jbc.RA118.004351.", "ArticleIdList": ["10.1074/jbc.RA118.004351", "PMC6177593", "30135205"]}, {"Citation": "McCubrey J. A., Lertpiriyapong K., Steelman L. S., et al. Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs. Aging (Albany NY) 2017;9(6):1477\u20131536. doi: 10.18632/aging.101250.", "ArticleIdList": ["10.18632/aging.101250", "PMC5509453", "28611316"]}, {"Citation": "Yin J., Xing H., Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712\u2013717. doi: 10.1016/j.metabol.2008.01.013.", "ArticleIdList": ["10.1016/j.metabol.2008.01.013", "PMC2410097", "18442638"]}, {"Citation": "Affuso F., Mercurio V., Fazio V., Fazio S. Cardiovascular and metabolic effects of berberine. World Journal of Cardiology. 2010;2(4):71\u201377. doi: 10.4330/wjc.v2.i4.71.", "ArticleIdList": ["10.4330/wjc.v2.i4.71", "PMC2999047", "21160701"]}, {"Citation": "Xie X., Chang X., Chen L., et al. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling. Molecular and Cellular Endocrinology. 2013;381(1-2):56\u201365. doi: 10.1016/j.mce.2013.07.019.", "ArticleIdList": ["10.1016/j.mce.2013.07.019", "23896433"]}, {"Citation": "Jeong H. W., Hsu K. C., Lee J. W., et al. Berberine suppresses proinflammatory responses through AMPK activation in macrophages. American Journal of Physiology. Endocrinology and Metabolism. 2009;296(4):E955\u2013E964. doi: 10.1152/ajpendo.90599.2008.", "ArticleIdList": ["10.1152/ajpendo.90599.2008", "19208854"]}, {"Citation": "Zhu L., Han J., Yuan R., Xue L., Pang W. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-\u03baB pathway. Biological Research. 2018;51(1):p. 9. doi: 10.1186/s40659-018-0157-8.", "ArticleIdList": ["10.1186/s40659-018-0157-8", "PMC5878418", "29604956"]}, {"Citation": "Wang C., Li J., Lv X., et al. Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin. European Journal of Pharmacology. 2009;620(1-3):131\u2013137. doi: 10.1016/j.ejphar.2009.07.027.", "ArticleIdList": ["10.1016/j.ejphar.2009.07.027", "19686728"]}, {"Citation": "Wang Y., Huang Y., Lam K. S. L., et al. Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. Cardiovascular Research. 2009;82(3):484\u2013492. doi: 10.1093/cvr/cvp078.", "ArticleIdList": ["10.1093/cvr/cvp078", "19251722"]}, {"Citation": "Zhang L. S., Zhang J. H., Feng R., et al. Efficacy and safety of berberine alone or combined with statins for the treatment of hyperlipidemia: a systematic review and meta-analysis of randomized controlled clinical trials. The American Journal of Chinise Medicine. 2019;47(4):751\u2013767. doi: 10.1142/S0192415X19500393.", "ArticleIdList": ["10.1142/S0192415X19500393", "31094214"]}, {"Citation": "Kim S. H., Shin E. J., Kim E. D., Bayaraa T., Frost S. C., Hyun C. K. Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes. Biological and Pharmaceutical Bulletin. 2007;30(11):2120\u20132125. doi: 10.1248/bpb.30.2120.", "ArticleIdList": ["10.1248/bpb.30.2120", "17978486"]}, {"Citation": "Zhou L., Yang Y., Wang X., et al. Berberine stimulates glucose transport through a mechanism distinct from insulin. Metabolism. 2007;56(3):405\u2013412. doi: 10.1016/j.metabol.2006.10.025.", "ArticleIdList": ["10.1016/j.metabol.2006.10.025", "17292731"]}, {"Citation": "Cok A., Plaisier C., Salie M. J., Oram D. S., Chenge J., Louters L. L. Berberine acutely activates the glucose transport activity of GLUT1. Biochimie. 2011;93(7):1187\u20131192. doi: 10.1016/j.biochi.2011.04.013.", "ArticleIdList": ["10.1016/j.biochi.2011.04.013", "PMC3526940", "21545824"]}, {"Citation": "Kong W., Wei J., Abidi P., et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature Medicine. 2004;10(12):1344\u20131351. doi: 10.1038/nm1135.", "ArticleIdList": ["10.1038/nm1135", "15531889"]}, {"Citation": "Lee Y. S., Kim W. S., Kim K. H., et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006;55(8):2256\u20132264. doi: 10.2337/db06-0006.", "ArticleIdList": ["10.2337/db06-0006", "16873688"]}, {"Citation": "Leng S. H., Lu F. E., Xu J. J. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacologica Sinca. 2004;25(4):496\u2013502.", "ArticleIdList": ["15066220"]}, {"Citation": "Tang L. Q., Wei W., Chen L. M., Liu S. Effects of berberine on diabetes induced by alloxan and a high-fat/high- cholesterol diet in rats. Journal of Ethnopharmacology. 2006;108(1):109\u2013115. doi: 10.1016/j.jep.2006.04.019.", "ArticleIdList": ["10.1016/j.jep.2006.04.019", "16759828"]}, {"Citation": "Zuo F., Nakamura N., Akao T., Hattori M. Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry. Drug Metabolism and Disposition: The Biological Fate of Chemicals. 2006;34(12):2064\u20132072. doi: 10.1124/dmd.106.011361.", "ArticleIdList": ["10.1124/dmd.106.011361", "16956957"]}, {"Citation": "Sol\u00e0 R., Valls R.-M., Puzo J., et al. Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized Trial. PLoS One. 2014;9(8):p. e101978. doi: 10.1371/journal.pone.0101978.", "ArticleIdList": ["10.1371/journal.pone.0101978", "PMC4118855", "25084280"]}, {"Citation": "Zeng X. H., Zeng X. J., Li Y. Y. Efficacy and safety of _berberine_ for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. The American Journal of Cardiology. 2003;92(2):173\u2013176. doi: 10.1016/S0002-9149(03)00533-2.", "ArticleIdList": ["10.1016/S0002-9149(03)00533-2", "12860219"]}, {"Citation": "Ahmed T., Gilani A.-u.-H., Abdollahi M., Daglia M., Nabavi S. F., Nabavi S. M. Berberine and neurodegeneration: a review of literature. Pharmacological Reports. 2015;67(5):970\u2013979. doi: 10.1016/j.pharep.2015.03.002.", "ArticleIdList": ["10.1016/j.pharep.2015.03.002", "26398393"]}, {"Citation": "Jiang W., Wei W., Gaertig M. A., Li S., Li X. J. Therapeutic effect of berberine on Huntington\u2019s disease transgenic mouse model. PLoS One. 2015;10(7):p. e0134142. doi: 10.1371/journal.pone.0134142.", "ArticleIdList": ["10.1371/journal.pone.0134142", "PMC4520448", "26225560"]}, {"Citation": "Kim M., Cho K.-H., Shin M.-S., et al. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson\u2019s disease. International Journal of Molecular Medicine. 2014;33(4):870\u2013878. doi: 10.3892/ijmm.2014.1656.", "ArticleIdList": ["10.3892/ijmm.2014.1656", "24535622"]}, {"Citation": "Panahi N., Mahmoudian M., Mortazavi P., Hashjin G. S. Experimental research Effects of berberine on \u03b2-secretase activity in a rabbit model of Alzheimer\u2019s disease. Archives of Medical Sciencie: AMS. 2013;1(1):146\u2013150. doi: 10.5114/aoms.2013.33354.", "ArticleIdList": ["10.5114/aoms.2013.33354", "PMC3598150", "23516061"]}, {"Citation": "Asai M., Iwata N., Yoshikawa A., et al. Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease A\u03b2 secretion. Biochemical and Biophysical Research Communication. 2007;352(2):498\u2013502. doi: 10.1016/j.bbrc.2006.11.043.", "ArticleIdList": ["10.1016/j.bbrc.2006.11.043", "17125739"]}, {"Citation": "Kwon I. H., Choi H. S., Shin K. S., et al. Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease. Neuroscience Letters. 2010;486(1):29\u201333. doi: 10.1016/j.neulet.2010.09.038.", "ArticleIdList": ["10.1016/j.neulet.2010.09.038", "20851167"]}, {"Citation": "Wang Y., Zhang S. Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2. Biomedicine & Pharmacotherapy. 2018;103:1287\u20131293. doi: 10.1016/j.biopha.2018.04.161.", "ArticleIdList": ["10.1016/j.biopha.2018.04.161", "29864910"]}, {"Citation": "Ahmadiankia N., Moghaddam H. K., Mishan M. A., et al. Berberine suppresses migration of MCF-7 breast cancer cells through down-regulation of chemokine receptors. Iranian Journal of Basic Medical Science. 2016;19(2):125\u2013131.", "ArticleIdList": ["PMC4818359", "27081456"]}, {"Citation": "Xie J., Xu Y., Huang X., et al. Berberine-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species generation and mitochondrial-related apoptotic pathway. Tumour Biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;36(2):1279\u20131288. doi: 10.1007/s13277-014-2754-7.", "ArticleIdList": ["10.1007/s13277-014-2754-7", "25352028"]}, {"Citation": "Chen Q. Q., Shi J. M., Ding Z., et al. Berberine induces apoptosis in non-small-cell lung cancer cells by upregulating miR-19a targeting tissue factor. Cancer Management and Research. 2019;11(11):9005\u20139015. doi: 10.2147/cmar.s207677.", "ArticleIdList": ["10.2147/cmar.s207677", "PMC6814314", "31695492"]}, {"Citation": "Abrams S. L., Follo M. Y., Steelman L. S., et al. Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells. Advances in Biological regulation. 2019;71:172\u2013182. doi: 10.1016/j.jbior.2018.10.003.", "ArticleIdList": ["10.1016/j.jbior.2018.10.003", "30361003"]}, {"Citation": "Wang Y., Kheir M. M., Chai Y., et al. Comprehensive study in the inhibitory effect of berberine on gene transcription, including TATA box. PLoS One. 2011;6(8):p. e23495. doi: 10.1371/journal.pone.0023495.", "ArticleIdList": ["10.1371/journal.pone.0023495", "PMC3161736", "21887260"]}, {"Citation": "Jiang S. X., Qi B., Yao W. J., et al. Berberine displays antitumor activity in esophageal cancer cellsin vitro. World Journal of Gastroenterology. 2017;23(14):2511\u20132518. doi: 10.3748/wjg.v23.i14.2511.", "ArticleIdList": ["10.3748/wjg.v23.i14.2511", "PMC5394514", "28465635"]}, {"Citation": "Cai Y., Xia Q., Luo R., et al. Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo. Journal of Natural Medicines. 2014;68(1):53\u201362. doi: 10.1007/s11418-013-0766-z.", "ArticleIdList": ["10.1007/s11418-013-0766-z", "23604974"]}, {"Citation": "Li F., Dong X., Lin P., Jiang J. Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells. International Journal of Molecular Science. 2018;19(2):p. 327. doi: 10.3390/ijms19020327.", "ArticleIdList": ["10.3390/ijms19020327", "PMC5855549", "29360760"]}, {"Citation": "Liu Z., Liu Q., Xu B., et al. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. Mutation Research. 2009;662(1-2):75\u201383. doi: 10.1016/j.mrfmmm.2008.12.009.", "ArticleIdList": ["10.1016/j.mrfmmm.2008.12.009", "19159633"]}, {"Citation": "Gao X., Wang J., Li M., et al. Berberine attenuates XRCC1-mediated base excision repair and sensitizes breast cancer cells to the chemotherapeutic drugs. Journal of Cellular and Molecular Medicine. 2019;23(10):6797\u20136804. doi: 10.1111/jcmm.14560.", "ArticleIdList": ["10.1111/jcmm.14560", "PMC6787507", "31338966"]}, {"Citation": "Meeran S. M., Katiyar S., Katiyar S. K. Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Toxicology and Applied Pharmacology. 2008;229(1):33\u201343. doi: 10.1016/j.taap.2007.12.027.", "ArticleIdList": ["10.1016/j.taap.2007.12.027", "18275980"]}, {"Citation": "El Khalki L., Maire V., Dubois T., Zyad A. Berberine Impairs the Survival of Triple Negative Breast Cancer Cells: Cellular and Molecular Analyses. Molecules. 2020;25(3):p. 506. doi: 10.3390/molecules25030506.", "ArticleIdList": ["10.3390/molecules25030506", "PMC7036777", "31991634"]}, {"Citation": "Wen C., Wu L., Fu L., Zhang X., Zhou H. Berberine enhances the anti-tumor activity of tamoxifen in drug-sensitive MCF-7 and drug-resistant MCF-7/TAM cells. Molecular Medicine Reports. 2016;14(3):2250\u20132256. doi: 10.3892/mmr.2016.5490.", "ArticleIdList": ["10.3892/mmr.2016.5490", "27432642"]}, {"Citation": "Piyanuch R., Sukhthankar M., Wandee G., Baek S. J. Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells. Cancer Letters. 2007;258(2):230\u2013240. doi: 10.1016/j.canlet.2007.09.007.", "ArticleIdList": ["10.1016/j.canlet.2007.09.007", "PMC2171032", "17964072"]}, {"Citation": "Wang N., Feng Y., Zhu M., et al. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. Journal of Cellular Biochemistry. 2010;111(6):1426\u20131436. doi: 10.1002/jcb.22869.", "ArticleIdList": ["10.1002/jcb.22869", "20830746"]}, {"Citation": "Wang K., Zhang C., Bao J., et al. Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death. Scientific Reports. 2016;6(1) doi: 10.1038/srep26064.", "ArticleIdList": ["10.1038/srep26064", "PMC4893614", "27263652"]}, {"Citation": "Agnarelli A., Natali M., Garcia-Gil M., et al. Cell-specific pattern of berberine pleiotropic effects on different human cell lines. Scientific Reports. 2018;8(1):p. 10599. doi: 10.1038/s41598-018-28952-3.", "ArticleIdList": ["10.1038/s41598-018-28952-3", "PMC6045596", "30006630"]}, {"Citation": "Kim S., Lee J., You D., et al. Berberine suppresses cell motility through downregulation of TGF-\u03b21 in triple negative breast cancer cells. Cellular Physiology and Biochemistry. 2018;45(2):795\u2013807. doi: 10.1159/000487171.", "ArticleIdList": ["10.1159/000487171", "29414799"]}, {"Citation": "Kim S., You D., Jeong Y., et al. Berberine down-regulates IL-8 expression through inhibition of the EGFR/MEK/ERK pathway in triple-negative breast cancer cells. Phytomedicine. 2018;50:43\u201349. doi: 10.1016/j.phymed.2018.08.004.", "ArticleIdList": ["10.1016/j.phymed.2018.08.004", "30466991"]}, {"Citation": "Liu C. H., Tang W. C., Sia P., et al. Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance. International Journal of Medical Sciences. 2015;12(1):63\u201371. doi: 10.7150/ijms.9982.", "ArticleIdList": ["10.7150/ijms.9982", "PMC4278877", "25552920"]}, {"Citation": "Tsang C. M., Cheung K. C. P., Cheung Y. C., et al. Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma. Biochimica et Biophysica Acta. 2015;1852(3):541\u2013551. doi: 10.1016/j.bbadis.2014.12.004.", "ArticleIdList": ["10.1016/j.bbadis.2014.12.004", "25496992"]}, {"Citation": "Choi M. S., Yuk D. Y., Oh J. H., et al. Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis. Anticancer Research. 2008;28(6A):3777\u20133784.", "ArticleIdList": ["19189664"]}, {"Citation": "Naveen C. R., Gaikwad S., Agrawal-Rajput R. Berberine induces neuronal differentiation through inhibition of cancer stemness and epithelial-mesenchymal transition in neuroblastoma cells. Phytomedicine. 2016;23(7):736\u2013744. doi: 10.1016/j.phymed.2016.03.013.", "ArticleIdList": ["10.1016/j.phymed.2016.03.013", "27235712"]}, {"Citation": "Maiti P., Plemmons A., Dunbar G. L. Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments. PLoS One. 2019;14(12):p. e0225660. doi: 10.1371/journal.pone.0225660.", "ArticleIdList": ["10.1371/journal.pone.0225660", "PMC6913937", "31841506"]}, {"Citation": "Kim D. W., Ahan S. H., Kim T. Y. Enhancement of arsenic trioxide (As2O3)- mediated apoptosis using berberine in human neuroblastoma SH-SY5Y cells. Journal of Korean Neurosurgical Society. 2007;42(5):392\u2013399. doi: 10.3340/jkns.2007.42.5.392.", "ArticleIdList": ["10.3340/jkns.2007.42.5.392", "PMC2588187", "19096576"]}, {"Citation": "Ji H.-F., Shen L. Molecular basis of inhibitory activities of berberine against pathogenic enzymes in Alzheimer's disease. The Scientific World Journal. 2012;2012:4. doi: 10.1100/2012/823201.823201", "ArticleIdList": ["10.1100/2012/823201", "PMC3259606", "22262957"]}, {"Citation": "Ugun-Klusek A., Theodosi T. S., Fitzgerald J. C., et al. Monoamine oxidase-A promotes protective autophagy in human SH-SY5Y neuroblastoma cells through Bcl-2 phosphorylation. Redox Biology. 2019;20:167\u2013181. doi: 10.1016/j.redox.2018.10.003.", "ArticleIdList": ["10.1016/j.redox.2018.10.003", "PMC6197572", "30336354"]}, {"Citation": "Fowler C. J., Benedetti M. S. The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone. Journal of Neurochemistry. 1983;40(6):1534\u20131541. doi: 10.1111/j.1471-4159.1983.tb08123.x.", "ArticleIdList": ["10.1111/j.1471-4159.1983.tb08123.x", "6406646"]}, {"Citation": "Calvani M., Cavallini L., Tondo A., et al. \u03923-adrenoreceptors control mitochondrial dormancy in melanoma and embryonic stem cells. Oxidative Medicine and Cellular Longevity. 2018;2018:10. doi: 10.1155/2018/6816508.6816508", "ArticleIdList": ["10.1155/2018/6816508", "PMC6258109", "30538804"]}]}], "History": [{"Year": "2020", "Month": "3", "Day": "27"}, {"Year": "2020", "Month": "7", "Day": "22"}, {"Year": "2020", "Month": "8", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["32855766", "PMC7443044", "10.1155/2020/7534693"]}}]}